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Abstract
Background
Internationally there is limited empirical evidence on the impact of overweight and obesity
on health service use and costs. We estimate the burden of hospitalisation—admissions,
days and costs—associated with above-normal BMI.
Methods
Population-based prospective cohort study involving 224,254 adults aged45y in Australia
(45 and Up Study). Baseline questionnaire data (2006-2009) were linked to hospitalisation
and death records (median follow-up 3.42y) and hospital cost data. The relationships be-
tween BMI and hospital admissions and days were modelled using zero-inflated negative
binomial regression; generalised gammamodels were used to model costs. Analyses were
stratified by sex and age (45-64, 65-79,80y), and adjusted for age, area of residence, ed-
ucation, income, smoking, alcohol-intake and private health insurance status. Population at-
tributable fractions were also calculated.
Results
There were 459,346 admissions (0.55/person-year) and 1,483,523 hospital days (1.76/per-
son-year) during follow-up. For ages 45-64y and 65-79y, rates of admissions, days and
costs increased progressively with increments of above-normal BMI. Compared to BMI
22.5-<25kg/m2, rates of admissions and days were 1.64-2.54 times higher for BMI
40-50kg/m2; costs were 1.14-1.24 times higher for BMI 27.5-<30kg/m2, rising to 1.77-2.15
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times for BMI 40-50kg/m2. The BMI-hospitalisation relationship was less clear for80y. We
estimated that among Australians 45-79y, around 1 in every 8 admissions are attributable
to overweight and obesity (2% to overweight, 11% to obesity), as are 1 in every 6 days in
hospital (2%, 16%) and 1 in every 6 dollars spent on hospitalisation (3%, 14%).
Conclusions
The dose-response relationship between BMI and hospital use and costs in mid-age and
older Australians in the above-normal BMI range suggests even small downward shifts in
BMI among these people could result in considerable reductions in their annual health care
costs; whether this would result in long-term savings to the health care system is not known
from this study.
Introduction
Obesity is a major global health concern. Rates of obesity have doubled or tripled in many
countries over the past three decades, and in almost half of all Organisation for Economic Co-
operation and Development countries 50% or more of the population is overweight or obese
[1,2]. In Australia, 63% of adults were classified as overweight (body mass index (BMI)25
kg/m2) or obese (BMI30 kg/m2) in 2011–12 [3], and the proportion of adults who are obese
has increased over time, up from 19% in 1995 to 28% in 2011–12. The proportion of adults
with very high BMI (>35 kg/m2) doubled from 5% to 10% over the same period [3].
The effect of the obesity epidemic on health care use and expenditure is of particular con-
cern. Primarily due to the increased risk of chronic diseases, such as diabetes, cardiovascular
disease, osteoarthritis and many cancers [4–6], obesity has been linked to excess use of hospital
and other health services, and consequently excess health care costs, in several countries, in-
cluding Australia [7–18]. Nevertheless, there is a paucity of reliable data world-wide on the im-
pact of overweight and obesity on health resource use and, in particular, associated costs [19].
Existing studies on costs have used varying methodologies; many have used a broad, top-down
approach [19,20], allocating costs to specific diseases associated with obesity, while fewer stud-
ies have used individual-level empirical data and prospective data. Further, with some excep-
tions [21,22], published cost estimates are largely based on broad BMI groupings and many
studies report only on obese groups; however, the overweight-but-not-obese groups are likely
to contribute materially to the burden [12]. Finally, the patterns of health service use in relation
to BMI vary considerably with age and sex [23,24], and the vast majority of studies have had in-
sufficient power to adequately quantify this variation, particularly in elderly populations, nor
to adjust for other factors to enable appropriate attribution of costs.
In Australia, hospitalisation accounts for the largest share of health care costs, around 40%
of total recurrent health expenditure [25]. The aim of this study was to use large-scale, popula-
tion-based survey data linked prospectively to hospital admission records to estimate the bur-
den of hospitalisation—including total admissions, days in hospital and costs—associated with
each narrow increment of above-normal BMI, in mid-age and older Australians.
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Materials and Methods
Study population and data sources
We used data from the Sax Institute’s 45 and Up Study, a prospective cohort study involving
267,153 men and women aged 45 years and over from New SouthWales (NSW), Australia. Par-
ticipants in the 45 and Up Study were randomly sampled from the database of Australia’s uni-
versal health insurance provider, Medicare, which provides virtually complete coverage of the
general population. Around 10% of the entire NSW population aged 45 years and over was in-
cluded in the cohort [26]. Participants joined the study by completing a baseline questionnaire,
distributed between 1 January 2006 and 31 December 2008, and provided signed consent for
linkage of their information to a range of health databases. The 45 and Up Study is described in
detail elsewhere [26], and questionnaires can be viewed at http://www.45andup.org.au.
For our study, baseline survey data were linked by the NSW Centre for Health Record Link-
age to individual hospitalisation data from the NSW Admitted Patient Data Collection (to
31 December 2011), which contains records of all hospitalisations in NSW. These data include
the Australian Refined Diagnosis Related Group (DRG) code for each admission [27]. Each
DRG represents a class of patients with similar clinical conditions requiring similar hospital re-
sources. Data were also linked to death registrations (to 31 December 2011), used in this study
for censoring purposes; and cancer registrations from the NSW Central Cancer Registry (Janu-
ary 2000–date of baseline survey) to ascertain cancer history.
Participants were followed from the date of recruitment to either December 2011 (the last
date to which hospital data were available) or date of death, whichever occurred first. Over the
relatively short follow-up period, a small but unknown number of participants are likely to
have moved out of NSW. Follow-up for hospitalisations is considered to be ~98% complete
among those continuing to reside in NSW [28]. Quality assurance data on the data linkage
show false positive and negative rates of<0.5% and<0.1%, respectively.
Participants were excluded from the analyses if they had: missing data on date of entry into
the study or BMI at baseline; a single record with DRG code/cost information missing; invalid
death or hospitalisation dates; or a cancer diagnosis within the five years before enrolment (ex-
cluding non-melanoma skin cancer), ascertained from the cancer registry (see S1 Fig.). Eligible
participants contributed person-years from the date of recruitment until the date of death or
end of follow up (31 December 2011), whichever was the earliest.
Hospitalisation outcomes. We investigated three outcomes: (i) total hospital admissions; (ii)
total days in hospital; and (iii) total hospitalisation costs (2009–10 Australian dollars). Where
patients had been transferred between hospitals, the relevant admission records were first
merged together to avoid double counting of unique hospital episodes. Total days in hospital
was based on length of stay (LOS, discharge date minus admission date, plus one day for same
day admissions), summed for all admissions. To assign costs, we matched the DRG codes in our
data to DRG-based cost data from the National Hospital Cost Data Collection Public Sector Es-
timated Cost Weights Reports (NHCDC) [29]. The NHCDC contains, amongst other informa-
tion, average costs per DRG, based on patient-costed and cost-modelled information. We used
the average DRG-specific total cost per admission in the Round 14 (2009–10) NHCDC to assign
costs to each admission in our dataset (version 5.2 for admissions from January 2006 to Decem-
ber 2009 and version 6.0x for admissions from January 2010 to December 2011) [29]. We as-
signed all costs using the Public Sector reports regardless of whether the admission was a private
or public hospital admission as the Private Sector reports do not include all component costs.
Body mass index. The main exposure, BMI, was calculated from weight and height, which
were self-reported on the baseline questionnaire. Consistent with established methods [30],
people with extreme measures of BMI (<15 kg/m2 or BMI>50 kg/m2) were excluded due to
Body Mass Index and Hospitalisation Rates and Costs
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the increased probability of measurement error. BMI was then categorised using the following
cut-points (World Health Organization (WHO) weight classification [31] in brackets):
15–18.49 (underweight), 18.5–19.99, 20–22.49 and 22.5–24.99 (normal weight), 25–27.49 and
27.5–29.99 (overweight), 30–32.49 and 32.5–34.99 (obese class I), 35–39.99 (obese class II) and
40–50 (obese class III).
Covariates
Covariates used in modelling, obtained from the baseline questionnaire (apart from area of res-
idence, which was obtained fromMedicare records), included age, sex, area of residence (cate-
gorised as major city, inner regional, more remote, based on the Accessibility/ Remoteness
Index of Australia Plus [32] score associated with the postcode of residence); education (no
school qualification, school certificate/trade/ apprenticeship, certificate/diploma/degree); pre-
tax annual household income (<$20,000, $20,000–29,999, $30,000–39,999, $40,000–49,999,
$50,000–69,999,$70,000 AUD), smoking (never, past, current), alcohol intake (0, 1-<15 and
15 drinks per week), and private health insurance (additional to universal health insurance,
categorised as yes, no). Participants with any missing values on any of these variables were as-
signed to a separate category for that variable in the analysis.
Statistical analysis
For each BMI category, we calculated total admissions, days in hospital and costs per person-
year. Rates were age-standardised to the 2006 NSW population, in 5 year age-groups, using the
direct method [33]. We modelled the relationship between BMI and each of the outcomes in
separate models, by sex and age group (45–64, 65–79 and80 years), adjusting for age at base-
line (5-year age groups) and all other covariates. For the80 years group, we combined the two
highest BMI categories due to small numbers. For admission rates and hospital days we used
zero-inflated negative binomial regression, with robust standard errors. For hospital costs we
used generalised linear models assuming a gamma distribution, with the selection of the specific
link functions guided by the fit of the data for each model; non-parametric bootstrapping was
used to generate confidence intervals [34]. Predicted estimates based on the fitted models were
calculated using the recycled predictions method, yielding adjusted average outcomes per BMI
category (i.e., assumes the same distribution of covariates in all BMI categories as in the entire
(age-sex specific) sample), with adjusted relative rates (RRs) estimated using 22.5-<25 kg/m2 as
the reference category. Tests for trend can also be performed by modelling median values of the
BMI categories as an ordinal variable. However, these were not performed as cumulative residu-
al plots used to investigate the linear functional form of BMI indicated that the assumption
about the linear functional form of BMI was often not satisfied. All statistical tests were two
sided, using a significance level of 5%. Analyses were performed using Stata version 13.1.
Finally, we estimated the proportion of hospital admissions, days and costs associated with
overweight and obesity by calculating population attributable fractions (PAFs) for those aged
45–79 years. To do this, within each age-sex group we calculated the attributable fractions
among the exposed in each above-normal BMI category (using the adjusted RRs generated ear-
lier), multiplied these by the proportion of admissions/days/costs in the corresponding BMI
category (i.e. the exposure prevalence among cases (Pcases)), (Pcases[((RR) - 1)/RR]), then
summed these for the relevant BMI categories, thus yielding internally valid PAFs for each age-
sex group [35]. In addition, as the above method reflects the distribution of BMI in the study
sample rather than the Australian population, instead of using the exposure prevalence among
the cases, we also generated PAFs by incorporating age-sex specific BMI prevalence in the Aus-
tralian population (Ppop), using data obtained from the 2011–12 Australian Health Survey
Body Mass Index and Hospitalisation Rates and Costs
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(refer to S1 Table) [36] ([Ppop (RR-1)/ Ppop (RR-1) + 1]) [35]. This method yields externally
valid PAFs on the strong assumption there is no confounding or effect modification affecting
the RRs. For both methods, we then weighted the age-sex-specific PAFs using the total admis-
sions/days/costs in the Australian population in the corresponding sex-age groups in 2011–12,
enabling us to estimate the overall PAFs and the absolute number of admissions, days in hospi-
tal and absolute costs associated with overweight and obesity in this combined age group
(45–79 years). Data on annual admissions and days in hospital in Australia by sex and age
group were obtained from published national data [28]. Data for annual hospital costs in Aus-
tralia by age and sex were not available for this study. Instead, we estimated the average cost
per admission by age and sex in our sample, and as these were based on 2009–10 cost data,
multiplied these by a government hospital inflation factor of 3.6% [37]; we then applied these
per admission costs to the total number of admissions in the Australian population in the cor-
responding age-sex groups to arrive at annual total costs.
Ethics approval for this project was obtained from the NSW Population and Health Services
Research Ethics Committee, the University of NSWHuman Research Ethics Committee and
the Australian National University Human Research Ethics Committee.
Results
After exclusions (S1 Fig.), we followed 224,254 participants (84%) over 842,051 person-years,
(median 3.42 years; range: 2 days to 6 years). In the final sample, 62% of participants were over-
weight or obese (40% and 22%, respectively), including two-thirds of men (47% overweight and
22% obese) and just over half of the women (33% overweight and 23% obese). This proportion
was considerably lower in those aged 80 years or older (47% overweight/obese). Just under half of
participants (47%) were men, with the majority (62%) aged 45–64 years and 10% aged 80 years or
older. Further characteristics of the sample, including missing data, are shown in Table 1.
A summary of hospitalisations occurring following study entry, presented separately by age
group and sex, are shown in S2 Table. The majority of participants (127,908, 57%) had at least
one hospital admission during the follow-up period. There were a total of 459,346 admissions
(0.55 per person-year), 1,483,523 days spent in hospital (1.76 per person-year) and $2,153 mil-
lion in hospitalisation costs ($2,557 per person-year). Just over one third (36.5%) of admissions
involved at least one overnight stay. The mean LOS per admission was 3.23 days (SD: 8.70),
and mean cost per admission was $4,681.
Age-standardised admissions, days in hospital and costs per person-year in relation to BMI
are shown in Fig. 1 (males) and Fig. 2 (females). For men and women aged 45–64 and 65–79, the
outcomes generally showed a J-shaped relationship with BMI. Rates were elevated at low BMI
levels (15-<18.5 kg/m2, and often also 18.5-<20 kg/m2), and they rose steadily with increasing
above-normal BMI. These same relationships were not evident in those aged 80 years or older.
Modelled estimates
Hospital admission rates in relation to BMI and associated relative rates, adjusted for all covariates,
are presented in Table 2. Hospitalisation rates increased with increasing above-normal BMI (>25
kg/m2 in those aged 45–64 years and>27.5 kg/m2 in those aged 65–79 years), such that rates for
those with BMI 40–50 kg/m2 were 1.7 to 2.2 times higher than in those with BMI 22.5-<25 kg/m2.
Amongst those 80 years or older, patterns were less clear and estimates were not significant.
Total days in hospital per person year in relation to BMI, adjusted for all covariates, are
presented in Table 3. The total number of days in hospital per person-year was also significant-
ly higher in those who were underweight compared to those with BMI 22.5-<25 kg/m2 among
males aged 45–64 and 65–79 years; also, the number of days increased incrementally with
Body Mass Index and Hospitalisation Rates and Costs
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increasing above-normal BMI among both males and females in these age-groups. In those
aged 80 years or older, total days in hospital per person-year were only significantly higher in
the low weight groups (<20 kg/m2) compared to BMI 22.5-<25 kg/m2.
Costs per person year in relation to BMI, adjusted for all covariates, are presented in
Table 4. The estimates of relative costs in the overweight and obese ranges were similar for
males and females in 45–64 and 65–79 age groups, being slightly elevated in the overweight
range (14–24% higher for BMI 27.5-<30 kg/m2), around 30% higher in the class I obesity
range (32.5–34.99 kg/m2) and rising to 80% to 115% higher amongst those with class III obesity
(40–50 kg/m2).
Notably, while the pattern and magnitude of RRs for admissions, days and costs in relation
to BMI were similar across age and sex, the corresponding absolute differences for overweight
and obese patients compared to normal weight patients were for the most part higher in men
than women and substantially higher in the 65–79 age group than the 45–64 age group.
Hospitalisation burden attributable to above-normal BMI. Using data from the study co-
hort, we estimated that the following were attributable to overweight and obesity for the 45–79
age group: 11% of hospital admissions (3% to overweight and 8% to obesity), 14% of days in
hospital (3% and 11%) and nearly 14% of hospital costs (around 4% and 9%) (Table 5). The
prevalence of high BMI in the general Australian population in 2011–12 was somewhat higher
than that in the study cohort [36]. Hence, the estimates of admissions, days and costs attribut-
able to overweight and obesity for the general population were slightly higher: over 600,000
hospital admissions, or 1 in every 8 admissions in this age group (around 2% to overweight
Table 1. Demographic and health characteristics of the sample.
BMI category (kg/m2) Total
sample
Underweight Normal weight Overweight Obese
15-<18.5 18.5-<20 20-<22.5 22.5-<25 25-<27.5 27.5-<30 30-<32.5 32.5-<35 35-<40 40–50
N 2826 6257 27 557 48 988 50 688 37 950 23 206 12 496 10 245 4041 224 254
% of total 1.3 2.8 12.3 21.9 22.6 16.9 10.4 5.6 4.6 1.8 100
Male 24.7 22.0 32.0 45.5 55.2 57.1 51.4 46.1 37.6 29.4 47.1
Age group
45–64 years 49.6 60.3 62.1 59.7 60.1 62.1 65.1 66.9 71.6 77.4 62.2
65–79 years 26.3 22.6 24.4 28.2 30.2 30.5 28.7 28.2 24.8 20.1 28.1
80 years 24.1 17.1 13.5 12.1 9.7 7.5 6.3 4.9 3.6 2.6 9.7
Lives in major city 47.4 50.7 48.9 47.8 45.3 43.5 42.4 40.4 39.4 40.0 45.2
Income $70 000 12.6 21.3 23.8 25.5 26.3 25.6 23.5 22.1 20.5 18.6 24.4
University degree 40.4 48.7 49.8 48.6 45.6 42.5 40.0 37.3 37.5 37.2 44.7
Health insurance
(yes)
56.4 62.9 66.6 68.1 68.2 67 64.7 61.5 58.7 52.7 66.0
Current smoker 16.1 10.8 9.0 7.1 6.3 6.2 6.7 7.0 7.2 7.7 7.2
Alcohol 15 drinks
p/w
8.5 8.2 10.3 13.4 16.4 17.3 16.3 15.0 11.9 7.9 14.4
Notes. 1.Cell numbers are percentage of the sample within each BMI category, except for % total where % refers to % of total sample in each
BMI category.
2. Participants with missing values are not included in the percentages (% missing: education = 1.44%; region = 0.02%; income = 20.88% (includes
refusal to disclose); smoking status = 0.30%; alcohol consumption = 1.92%; physical activity = 1.87%; other variables = <0.01%).
doi:10.1371/journal.pone.0118599.t001
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Fig 1. Age-standardised hospital admissions, days in hospital and costs per person-year (with 95% CIs) by bodymass index (BMI), males.Notes.
1. Within each age group, rates are age-standardised to the 2006 NSW population (in 5 year age-groups) using the direct method.
doi:10.1371/journal.pone.0118599.g001
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Fig 2. Age-standardised hospital admissions, days in hospital and costs per person-year (with 95% CIs) by bodymass index (BMI), females.
Notes. 1. Within each age group, rates are age-standardised to the 2006 NSW population (in 5 year age-groups) using the direct method. 2. The upper
confidence interval for the 80 years or older age group for hospital admissions has been truncated to 4.1 (actual value is 4.8).
doi:10.1371/journal.pone.0118599.g002
Body Mass Index and Hospitalisation Rates and Costs
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and 11% to obesity); over 2 million days in hospital, or one in every 6 days (2% and 16%) and
around $3.8 billion in total costs, or 1 in every 6 dollars spent (3% and 14%) (Table 5).
Discussion
In mid-age and older Australian adults, admission rates and total days in hospital rise with in-
creasing above-normal BMI. These elevated rates, combined with the high prevalence of over-
weight and obesity in the Australian population, result in substantial excess hospital costs,
estimated to be around 17% of total hospital costs, or nearly four billion dollars, in the 45–79
year age group alone in 2011–12. Although the excess burden is mostly attributed to obesity
rather than overweight, the total attributed to people in the overweight range (25-<30 kg/m2)
is still substantial, underlying the importance of including estimates for burden associated with
overweight, not just obesity.
While previous studies have mostly shown increased hospitalisation rates and costs associ-
ated with obesity, their relationship with lower levels of BMI are less well established, with
mixed findings regarding the excess hospitalisation rates and costs in the overweight range and
in the elderly [7,17,18,24,38–40]. Some of this inconsistency may be explained by the fact that
broad BMI categories are used in most studies, often necessary due to lack of power to
Table 2. Estimated hospital admission rates by body mass index (BMI)(1).
45–64 years 65–79 years 80 years
BMI
category
Average admissions
per py
Relative Rate
(95% CI)
Average admissions
per py
Relative Rate
(95% CI)
Average admissions
per py
Relative Rate
(95% CI)
Males
15-<18.5 0.81 2.50 (0.91–6.82) 1.59 1.94 (0.85–4.43) 1.36 1.03 (0.84–1.28)
18.5-<20 0.26 0.78 (0.65–0.93) 1.47 1.79 (1.07–2.99) 1.55 1.17 (0.73–1.86)
20-<22.5 0.31 0.95 (0.81–1.12) 0.78 0.95 (0.78–1.16) 1.77 1.34 (1.04–1.71)
22.5-<25 0.33 1.00 0.83 1.00 1.33 1.00
25-<27.5 0.36 1.10 (0.98–1.24) 0.81 0.97 (0.85–1.11) 1.52 1.14 (0.94–1.38)
27.5-<30 0.42 1.24 (1.09–1.41) 0.93 1.12 (0.96–1.31) 1.40 1.05 (0.87–1.27)
30-<32.5 0.41 1.23 (1.09–1.39) 1.01 1.20 (1.02–1.42) 1.85 1.39 (0.95–2.02)
32.5-<35 0.50 1.49 (1.20–1.85) 1.03 1.23 (0.99–1.52) 1.83 1.37 (0.80–2.34)
35-<40(2) 0.51 1.49 (1.18–1.89) 1.30 1.57 (1.17–2.12) 2.00 1.50 (0.64–3.53)
40–50 0.73 2.19 (1.42–3.38) 1.42 1.70 (1.12–2.57)
Females
15-<18.5 0.30 0.98 (0.82–1.17) 0.89 1.31 (0.84–2.04) 1.40 1.40 (0.88–2.25)
18.5-<20 0.32 1.06 (0.82–1.38) 0.60 0.88 (0.72–1.07) 1.04 1.04 (0.77–1.41)
20-<22.5 0.30 1.01 (0.89–1.14) 0.71 1.04 (0.84–1.28) 1.09 1.09 (0.86–1.38)
22.5-<25 0.30 1.00 0.68 1.00 1.00 1.00
25-<27.5 0.33 1.10 (0.96–1.26) 0.64 0.93 (0.80–1.09) 0.93 0.93 (0.76–1.14)
27.5-<30 0.35 1.14 (1.02–1.26) 0.72 1.04 (0.86–1.26) 1.13 1.13 (0.83–1.53)
30-<32.5 0.38 1.25 (1.09–1.44) 0.85 1.23 (0.97–1.55) 0.88 0.88 (0.74–1.06)
32.5-<35 0.40 1.31 (1.16–1.47) 0.83 1.19 (0.96–1.47) 0.94 0.95 (0.76–1.20)
35-<40(2) 0.44 1.42 (1.27–1.58) 0.91 1.30 (1.03–1.64) 1.37 1.38 (0.70–2.70)
40–50 0.51 1.64 (1.43–1.87) 1.18 1.74 (1.00–3.01)
py = person year
1. Within each age-sex group, adjusted for age, income, education, health insurance, region, smoking status and alcohol consumption.
2. In 80 years age group, this category also includes those with BMI 40–50 kg/m2.
doi:10.1371/journal.pone.0118599.t002
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investigate finer BMI groupings. In our large study, using finer categories of BMI, we were able
to show clear patterns of increasing hospitalisation rates, days in hospital and costs with in-
creasing above-normal normal BMI, predominantly in those aged 45–79.
Admission rates, days in hospital and hospital costs were lowest in those with a BMI range
of around 20-<25 kg/m2. This is similar to the findings from prospective studies in other coun-
tries that examined admissions [40] and costs [21,22] in relation to narrow BMI categories. Im-
portantly, we found that hospitalisation rates and costs in men were for the most part elevated
in the low-normal BMI range (18.5-<20 kg/m2), relative to BMI 20-<22.5 kg/m2, which
means if the broad WHO category of normal weight is used as the reference group (i.e.
18.5-<25 kg/m2) the excess risk associated with overweight and obesity may be underesti-
mated, as has been illustrated in studies of BMI and mortality [41]. That mean costs were high
in the underweight groups, particularly amongst men, is likely to reflect reverse causality (with
poor health leading to weight loss). In a study comparable to ours, but where follow-up time
was longer and those who died in the first five years were excluded, there were less marked
(and often not significant) differences in the costs for underweight and normal weight partici-
pants [21]. That the relationship between BMI and hospitalisation use and costs is less clear in
Table 3. Estimated days in hospital per person year, by body mass index (BMI) (1).
45–64 years 65–79 years 80 years
BMI
category
Average days per
py
Relative Rate (95%
CI)
Average days per
py
Relative Rate (95%
CI)
Average days per
py
Relative Rate (95%
CI)
Males
15-<18.5 1.90 2.19 (1.22–3.96) 8.97 3.02 (1.94–4.69) 14.42 1.85 (1.37–2.51)
18.5-<20 0.99 1.17 (0.82–1.65) 6.03 2.00 (1.45–2.77) 10.53 1.35 (1.06–1.71)
20-<22.5 0.95 1.17 (0.97–1.43) 3.45 1.16 (0.99–1.36) 9.25 1.17 (1.03–1.34)
22.5-<25 0.84 1.00 3.01 1.00 7.88 1.00
25-<27.5 0.92 1.08 (0.97–1.21) 2.81 0.93 (0.84–1.03) 8.01 1.01 (0.91–1.13)
27.5-<30 1.07 1.25 (1.12–1.39) 3.24 1.07 (0.96–1.19) 8.45 1.07 (0.94–1.22)
30-<32.5 1.20 1.39 (1.23–1.57) 3.65 1.19 (1.05–1.35) 9.56 1.21 (1.01–1.44)
32.5-<35 1.27 1.46 (1.25–1.70) 4.18 1.36 (1.17–1.58) 10.19 1.28 (0.97–1.70)
35-<40(2) 1.60 1.80 (1.49–2.18) 4.75 1.57 (1.31–1.87) 10.21 1.29 (0.93–1.78)
40–50 2.22 2.54 (1.99–3.24) 6.37 2.06 (1.58–2.69)
Females
15-<18.5 0.90 1.26 (0.96–1.65) 3.67 1.66 (1.25–2.20) 10.39 1.56 (1.27–1.92)
18.5-<20 0.80 1.13 (0.93–1.39) 2.53 1.17 (0.94–1.45) 7.57 1.14 (0.97–1.34)
20-<22.5 0.71 1.00 (0.87–1.14) 2.59 1.18 (1.03–1.36) 6.95 1.06 (0.92–1.21)
22.5-<25 0.72 1.00 2.20 1.00 6.63 1.00
25-<27.5 0.81 1.12 (0.98–1.27) 2.28 1.03 (0.90–1.18) 6.24 0.95 (0.83–1.09)
27.5-<30 0.87 1.18 (1.05–1.33) 2.35 1.05 (0.92–1.20) 7.19 1.09 (0.92–1.28)
30-<32.5 0.96 1.29 (1.13–1.48) 2.87 1.27 (1.10–1.48) 7.05 1.07 (0.89–1.30)
32.5-<35 1.08 1.45 (1.26–1.67) 3.06 1.35 (1.14–1.60) 6.47 0.98 (0.76–1.26)
35-<40(2) 1.26 1.69 (1.48–1.93) 3.78 1.68 (1.40–2.00) 7.45 1.13 (0.86–1.48)
40–50 1.65 2.15 (1.79–2.58) 4.99 2.24 (1.68–2.99)
py = person year
1. Within each age-sex group, adjusted for age, income, education, health insurance, region, smoking status and alcohol consumption.
2. In 80 years age group, this category also includes those with BMI 40–50 kg/m2.
doi:10.1371/journal.pone.0118599.t003
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the elderly (80 years) also needs to be taken into account when estimating the burden attrib-
utable to high BMI in the population.
The total proportion of hospital admissions attributed to overweight and obesity in our
study was substantial, at around 13% of total admissions (2% for overweight, 11% for obesity)
Table 4. Estimated hospital costs per person year, by body mass index (BMI)(1).
45–64 years 65–79 years 80 years
BMI category Costs per py Relative Rate (95% CI) Costs per py Relative Rate (95% CI) Costs per py Relative Rate (95% CI)
Males
15-<18.5 2346 1.62 (1.08–2.32) 5939 1.59 (1.19–2.07) 7078 1.07 (0.90–1.27)
18.5-<20 1331 0.92 (0.76–1.09) 5649 1.51 (1.23–1.81) 7189 1.09 (0.96–1.24)
20-<22.5 1344 0.93 (0.86–1.01) 3769 1.01 (0.94–1.07) 7076 1.07 (1.00–1.14)
22.5-<25 1444 1.00 3745 1.00 6599 1.00
25-<27.5 1564 1.08 (1.04–1.13) 3742 1.00 (0.97–1.03) 7015 1.06 (1.01–1.12)
27.5-<30 1739 1.20 (1.15–1.26) 4289 1.15 (1.10–1.19) 7289 1.10 (1.04–1.18)
30-<32.5 1862 1.29 (1.23–1.36) 4763 1.27 (1.20–1.35) 7965 1.21 (1.09–1.34)
32.5-<35 2031 1.41 (1.30–1.53) 5369 1.43 (1.32–1.55) 7653 1.16 (1.01–1.32)
35-<40(2) 2401 1.66 (1.52–1.83) 5678 1.52 (1.37–1.66) 8251 1.25 (1.00–1.55)
40–50 2823 1.95 (1.65–2.28) 6644 1.77 (1.45–2.08)
Females
15-<18.5 1220 1.06 (0.89–1.24) 3614 1.31 (1.11–1.53) 6526 1.20 (1.06–1.35)
18.5-<20 1101 0.96 (0.86–1.06) 2870 1.04 (0.91–1.18) 5821 1.07 (0.97–1.18)
20-<22.5 1118 0.97 (0.92–1.02) 2946 1.07 (1.00–1.14) 5649 1.04 (0.97–1.11)
22.5-<25 1152 1.00 2764 1.00 5422 1.00
25-<27.5 1250 1.09 (1.03–1.14) 2979 1.08 (1.02–1.13) 5249 0.97 (0.91–1.03)
27.5-<30 1424 1.24 (1.18–1.29) 3144 1.14 (1.08–1.20) 5727 1.06 (0.97–1.14)
30-<32.5 1528 1.33 (1.26–1.41) 3568 1.29 (1.22–1.39) 5568 1.03 (0.92–1.13)
32.5-<35 1754 1.52 (1.42–1.63) 3766 1.36 (1.26–1.48) 5544 1.02 (0.87–1.18)
35-<40(2) 2015 1.75 (1.65–1.86) 4497 1.63 (1.49–1.78) 6276 1.16 (0.98–1.37)
40–50 2480 2.15 (1.98–2.35) 5032 1.82 (1.54–2.14)
py = person year
1. Within each age-sex group adjusted for current age, income, education, health insurance, region, smoking status and alcohol consumption.
2. In 80 years age group, this category also includes those with BMI 40–50 kg/m2.
doi:10.1371/journal.pone.0118599.t004
Table 5. Hospitalisation burden attributable to overweight and obesity in the study cohort and the
Australian population aged 45–79 years in 2011–12.
Admissions Days Costs ($million)
PAF (%) Total PAF (%) Total PAF (%) Total
PAFs from study cohort
Overweight 3.02 150 819 3.04 412 769 4.10 920
Obese 7.63 380 660 11.22 1 522 296 9.44 2117
Total overweight and obese 10.66 531 478 14.26 1 935 065 13.54 3037
PAFs incorporating 2011-12 Australian BMI prevalence data
Overweight 2.13 106 128 1.90 257 306 3.13 703
Obese 11.08 552 605 15.72 2 133 721 13.97 3134
Total overweight and obese 13.21 658 732 17.62 2 391 027 17.10 3837
doi:10.1371/journal.pone.0118599.t005
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or 1 in every 8 admissions. A recent prospective study of hospitalisation rates in the UK esti-
mated very similar attributable fractions, 3% for overweight and 9% for obesity in the popula-
tion aged 50–85 [40]. There are no directly comparable previous estimates for Australia.
While our study only examined hospitalisation rates and costs, it is likely that use of other
health care resources, including ambulatory medical care and pharmaceuticals, also increase
with increasing BMI. For example, an earlier study of mid-age Australian women using linked
Medicare records (essentially out-of-hospital medical and pathology services), found excess
costs in obese women and in sedentary overweight women [15]. International studies also
showed increased costs across different types of care. In a recent empirical study of working-
age adults in the US, medical (including hospital inpatient and ambulatory care) and pharma-
ceutical costs both rose gradually with increasing BMI, starting from a BMI of 19 kg/m2 [22].
Similarly, in a Japanese study, physician visits and outpatient costs rose incrementally from a
BMI of 18.5–20.9 kg/m2, while inpatient days in hospital and costs showed a J-shaped relation-
ship with BMI as in our study, with estimates lowest for BMI 23–24.9 kg/m2 [17]. In addition,
there are also likely to be increased costs outside the health care sector associated with over-
weight and obesity, such as those related to absenteeism and lost productivity. In a previous
Australian study based on retrospective self-report of service use in people aged25 years,
there were considerable excess costs associated with overweight and obesity for health care
(hospitalisation, ambulatory services and pharmaceuticals), non-health care (e.g. transport to
hospital, special food) and government subsidies (e.g. disability pension) [12].
Although difficult to compare directly across populations, health systems and time periods,
our finding of 17% of hospital costs attributable to overweight and obesity is generally higher
than found in studies examining total healthcare expenditures, which show attributable frac-
tions mostly in the range of 2–4%, but as high as 12% [14,16,19,40]. Findings from internation-
al studies on total health care costs also differ in terms of the relative contributions of
overweight versus obesity [16,18,40,42], with costs attributable to overweight vs obesity rang-
ing from 3% vs 97% in a Swedish study [18] to 34% vs 66% in a Canadian study [16], compared
to 20% vs 80% in our study on hospital costs.
Major strengths of our study are: (i) its large sample size, enabling examination of outcomes
separately by age group and sex in relation to narrow BMI increments; (ii) the availability of
data on a range of potential confounders, allowing covariate adjustments; (iii) virtually com-
plete follow-up data on hospitalisations (and deaths for censoring); and (iv) availability of
DRG-specific nationally-collected costs. There are several limitations that should be borne in
mind when interpreting the results: (i) Data on exposures were mostly based on self-report;
this included BMI, which was calculated using self-reported weight and height at baseline. Al-
though people tend to underestimate their weight and overestimate their height [43], and con-
sequently underestimate BMI, a validation study involving participants in the 45 and Up Study
revealed that the mean difference between self-reported and measured BMI was not large (on
average-0.74 kg/m2) and correlations between self-reported and measured height and weight
were 0.95 and 0.99, respectively [44]; however, it is also likely that, at least in people<65 years
of age, BMI at time of admission would be higher than at baseline as people in this age group
tend to put on weight over time; (ii) Because a dose—response relationship in outcomes with
above-normal BMI was evident after adjustment for a range of important confounders, we as-
sumed these incremental outcomes could be attributed to above-normal BMI. This assumes
full adjustment of relevant factors has been achieved, nevertheless a contribution of residual
confounding to the estimates cannot be ruled out. Further, due to the relatively short follow up
period, we cannot rule out the effect of pre-existing disease at baseline on BMI, although we
did exclude patients with a history of cancer at baseline; (iii) The costs assigned to each individ-
ual are indicative only as they are based on the DRG-specific average costs of public hospital
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care and they are not sensitive to individual variations in resource use within DRG categories;
(iv) While the 45 and Up cohort are broadly representative of the Australian population in this
age group, they are likely to be healthier, and have lower hospitalisation rates than the general
population in this age group. However, given the near-complete follow up of the cohort and
other methodological considerations, internal comparisons of rates and costs are valid and care
was taken to use representative population estimates of BMI when estimating population at-
tributable fractions [45]. Consequently, we suggest more emphasis be placed on the relative,
than on the absolute, rates and costs of hospital admissions; (v) Finally, these data do not allow
estimation of the hospitalisation burden attributable to obesity and overweight in younger
adults and children, but excess burden is likely in these age groups.
Conclusion
Our empirical, prospective data show considerable excess annual hospital admissions, days and
costs associated with above-normal BMI in mid-age and older Australians, starting in the over-
weight range, although uncertainties remain regarding optimal BMI in the elderly. While the
total excess burden associated with overweight is substantial, the markedly elevated hospitalisa-
tion rates and costs in obese BMI groups, including class I obesity, is of particular concern. This
is not only an issue for individuals in this BMI range; it places a large burden on the health sys-
tem, which is likely to increase as the proportion in these higher BMI ranges has been rising [3].
The dose-response relationship between BMI and hospital costs in mid-age and older Austra-
lians in the above-normal BMI range suggests that even small downward shifts in BMI among
these people could result in considerable reductions in their annual health care costs. However,
whether this would result in long-term savings to the health care system is not known from this
study as it was beyond the scope of this paper to model lifetime health care costs. Results from
previous studies on lifetime medical costs of obesity are mixed (e.g. [46–48]).
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